Beranda › Kanker Hipofaring
Uji klinis Kanker Hipofaring yang merekrut di AS
19 studi untuk Kanker Hipofaring merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Atlanta, GA6 studi
- Chicago, IL6 studi
- Stevens Point, WI5 studi
- Richmond, VA5 studi
- Bloomington, IL5 studi
- Wausau, WI5 studi
- Peoria, IL5 studi
- Joliet, IL5 studi
- Cape Girardeau, MO5 studi
- Milwaukee, WI5 studi
- Kansas City, MO5 studi
- New York City, NY4 studi
- Queens, NY4 studi
- Edison, NJ4 studi
- North Peoria, IL4 studi
- Aurora, IL4 studi
- Charleston, IL4 studi
- Evanston, IL4 studi
- Danville, IL4 studi
- Flint, MI4 studi
- Duluth, MN4 studi
- Fargo, ND4 studi
- Bozeman, MT4 studi
- Naperville, IL4 studi
- Green Bay, WI4 studi
- Galesburg, IL4 studi
- St. Louis, MO4 studi
- Cedar Rapids, IA4 studi
- Decatur, IL4 studi
- Waterford, MI4 studi
- Waukegan, IL4 studi
- Champaign, IL4 studi
- Cicero, IL4 studi
- Oklahoma City, OK4 studi
- Omaha, NE4 studi
- Lansing, MI4 studi
- Pittsburgh, PA4 studi
- Cincinnati, OH4 studi
- Louisville, KY4 studi
- Baltimore, MD4 studi
Berdasarkan negara bagian
- Arizona3 studi
- Arkansas4 studi
- California7 studi
- Colorado6 studi
- Florida8 studi
- Georgia6 studi
- Idaho3 studi
- Illinois7 studi
- Indiana4 studi
- Iowa6 studi
- Kansas6 studi
- Kentucky4 studi
- Maryland5 studi
- Massachusetts5 studi
- Michigan5 studi
- Minnesota6 studi
- Missouri6 studi
- Montana4 studi
- Nebraska4 studi
- New Jersey4 studi
- New York8 studi
- North Carolina5 studi
- North Dakota4 studi
- Ohio8 studi
- Oklahoma4 studi
- Oregon3 studi
- Pennsylvania6 studi
- South Dakota3 studi
- Texas3 studi
- Virginia5 studi
- Wisconsin6 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06589804Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States Population
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06997068BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT05136196Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05172245Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT02734537Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07156227Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT06532279Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07441681Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT04198766Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jul 2026 · NCT06662058Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT01365169Integrated Cancer Repository for Cancer Research
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Apr 2026 · NCT03010150TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Mar 2026 · NCT06868433A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Feb 2026 · NCT07063212Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Feb 2026 · NCT06636734Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Feb 2026 · NCT01473784Comparing an Investigational Scan (F-18 NaF PET/CT) to Standard of Care Imaging (F-18 FDG PET/CT) for Evaluating Vascular Complications in Patients Receiving Radiation Therapy for Head and Neck Cancer
Menerima pesertaFase awal 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Okt 2025 · NCT06914999Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Menerima pesertaStudi observasional
Usia 21 hingga 90 · Semua jenis kelamin · Diperbarui 22 Sep 2025 · NCT00900419Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.